Dimethyldihydropyridine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Dimethyldihydropyridine
• 英文别名: 3,5-dimethyl-1,2-dihydropyridine
• 化学式: C₇H₁₁N
• 分子量: 109.17
• InChiKey: CTAANKPFWDAPSQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• HETEROCYCLIC COMPOUND AND USE THEREOF
  申请人：Taniguchi Takahiko

  公开号：US20130137675A1

  公开（公告）日：2013-05-30

  The present invention aims to provide a compound having a PDE inhibitory action and useful as a medicament for the prophylaxis or treatment of schizophrenia and the like. A compound represented by the formula (1 x ): wherein each symbol is as described in the DESCRIPTION, or the formula (1): W 1 —W 2 (1) wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

  本发明旨在提供一种具有PDE抑制作用并且用作预防或治疗精神分裂症等疾病的药物的化合物。 由式（1）表示的化合物： 其中每个符号如描述中所述，或式（1）： W1-W2（1） 其中每个符号如描述中所述， 或其盐。
• METHYL/DIFLUOROPHENYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS, METHYL-PYRIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS, AND METHYL-PYRIMIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS
  申请人：Confluence Life Sciences INC.

  公开号：US20130274272A1

  公开（公告）日：2013-10-17

  The present disclosure provides methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and auto-inflammatory disease, having the structure of Formula (I): wherein R 1 , R 2 , R 3 and X are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound.

  本公开提供了甲基/二氟苯基-甲氧基取代的吡啶酮-吡啶基化合物，甲基-吡啶基-甲氧基取代的吡啶酮-吡啶基化合物，以及甲基-嘧啶基-甲氧基取代的吡啶酮-吡啶基化合物，其结构式为（I），可用于治疗p38激酶介导的疾病，如淋巴瘤和自身免疫性疾病，其中R1、R2、R3和X如详细说明中所定义；包括至少一种该化合物的药物组合物；以及使用该化合物治疗p38激酶介导的疾病的方法。
• ORGANIC EL ELEMENT AND SOLUTION CONTAINING ORGANIC EL MATERIAL
  申请人：Idemitsu Kosan Co., Ltd.

  公开号：EP2221897A1

  公开（公告）日：2010-08-25

  An organic electroluminescence device (1) includes: an anode (3); a cathode (4); and an organic thin-film layer (10) interposed between the anode (3) and the cathode (4). The organic thin-film layer (10) includes a phosphorescent-emitting layer (5) containing a host and a phosphorescent dopant. The host contains a first host and a second host. The first host includes a substituted or unsubstituted polycyclic fused aromatic skeleton, the skeleton having 10 to 30 ring-forming atoms not including an atom of a substituent. The second host has an affinity level greater than the affinity level of the first host

  一种有机电致发光装置（1）包括：阳极（3）；阴极（4）；以及位于阳极（3）和阴极（4）之间的有机薄膜层（10）。有机薄膜层（10）包括一个磷光发光层（5），其中包含一个宿主和一个磷光掺杂剂。宿主包含第一宿主和第二宿主。第一宿主包括一个取代或未取代的多环融合芳香族骨架，该骨架具有 10 至 30 个成环原子，其中不包括一个取代基原子。第二宿主的亲和力大于第一宿主的亲和力
• AROMATIC POLYMER ION EXCHANGE MEMBRANE AND ITS COMPLEX MEMBRANE AND ITS APPLICATION FOR ACIDIC ELECTROLYTE FLOW ENERGY STORAGE BATTERY
  申请人：Dalian Institute Of Chemical Physics, Chinese Academy of Sciences

  公开号：EP2490279B1

  公开（公告）日：2017-08-02
• N-(4-{[PYRIDIN-3-YL-METHYL)CARBAMOYL]AMINO}BENZENE-SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER
  申请人：Forma TM, LLC.

  公开号：EP2611777B1

  公开（公告）日：2016-05-11